Evidence map›Paper›PMID 40828543›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2025

Randomized Controlled Trial of a HIV Prevention App to Increase Pre-exposure Prophylaxis Uptake Among Gay and Bisexual Men Who Have Sex With Men in the United States: The HealthMindr PrEP Study.

Jeb Jones, Isaac Schneider, Rachel Valencia, Samuel M Jenness, Gareth Butler, Amanda D Castel, Paige Kulie, Rob Stephenson, Joanne D Stekler, Leandro Mena and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jeb JonesDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.ORCID 0000-0001-9165-1658
Isaac SchneiderDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Rachel ValenciaDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Samuel M JennessDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Gareth ButlerDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Amanda D CastelDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC.
Paige KulieDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington, DC.
Rob StephensonDepartment of Systems, Populations and Leadership, School of Nursing, University of Michigan, Ann Arbor, MI.
Joanne D SteklerDivision of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA; and.
Leandro MenaDepartment of Medicine, Emory University, Atlanta, GA.
Patrick S SullivanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.

Funding

Theoretically Based Mobile App to Increase PrEP Uptake Among MSMR01DA045612 · NIDA · EMORY UNIVERSITY · PI SULLIVAN, PATRICK SEAN · 2017 to 2021
$5.2M
STI Response and Recommendations Under PrEP (STIRRUP)R01MH128130 · NIMH · EMORY UNIVERSITY · PI Samuel Jenness · 2022 to 2026
$3.1M
NIDA NIH HHS R01 DA045612NIDA NIH HHS R01DA045612NIMH NIH HHS R01 MH128130
6 · The paper itself

Abstract

backgroundWe tested an adaptation of a mobile HIV prevention smartphone app, HealthMindr-PrEP, to assess its effectiveness to increase pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men who have sex with men.

settingThis study was conducted online among gay and bisexual men who have sex with men living in Ending the HIV Epidemic priority jurisdictions, primarily in the southern United States.

methodsWe conducted a randomized controlled trial in which participants were randomly assigned to receive the intervention app or an app that only allowed participants to track their study progress. The primary outcome was self-reported PrEP uptake. Cox proportional hazards models were used to compare the rate of PrEP uptake across study arms.

resultsAlthough no results were statistically significant, the rate of PrEP initiation was higher among participants in the intervention arm compared with the control arm, particularly among participants with PrEP indications at baseline. Among those with PrEP indications at baseline, participants in the intervention arm had a 64% higher rate of PrEP initiation compared with the control arm (hazard ratio = 1.64, 95% CI: 0.89 to 3.03). Among those without PrEP indications, the same hazard ratio was 1.05 (95% CI: 0.67 to 1.66).

conclusionsOur results suggest that HealthMindr-PrEP increases the rate of PrEP uptake compared with a standard of care control condition; however, we had insufficient statistical power for stratified analyses that demonstrated that the strongest effect was among those who had PrEP indications at baseline.

Indexed as

Anti-HIV AgentsHIV InfectionsHomosexuality, MaleMobile ApplicationsPre-Exposure ProphylaxisSexual and Gender MinoritiesAdultBisexualityHumansMaleMiddle AgedUnited StatesYoung AdultAnti-HIV AgentsHIVinterventionmen who have sex with menmHealthpre-exposure prophylaxisrandomized controlled trial

Identifiers

PMID40828543
PMCPMC13628309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.